{"@id":"https://bioecon.ru/technology/translational-pharmaceutics/","@type":"Technology","cluster":"therapeutics-platforms","formats":{"html":"https://en.bioecon.ru/technology/translational-pharmaceutics/","json":"https://en.bioecon.ru/api/v1/technology/translational-pharmaceutics/index.json"},"id":"translational-pharmaceutics","industries":["pharma","biomanufacturing"],"lang":"en","links":{"industries":["https://bioecon.ru/industries/pharma/","https://bioecon.ru/industries/biomanufacturing/"],"suppliers":["https://bioecon.ru/companies/genmab/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/novartis/","https://bioecon.ru/companies/recursion-pharmaceuticals/","https://bioecon.ru/companies/insilico-medicine/","https://bioecon.ru/companies/esco-aster/","https://bioecon.ru/companies/biohaven/","https://bioecon.ru/companies/syncozymes/","https://bioecon.ru/companies/imperagen/","https://bioecon.ru/companies/iontech-2000-jsc/","https://bioecon.ru/companies/formulaciones-quimicas-sa/","https://bioecon.ru/companies/mgi/"]},"maturity":8,"name":"Translational Pharmaceutics Integrated Formulation and Clinical Testing","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Real-time clinical batch manufacture"},{"n":2,"title":"Adaptive clinical protocol dosing"},{"n":3,"title":"Rapid iteration cycle"},{"n":4,"title":"Formulation de-risking for Phase II"}],"summary":"An integrated closed-loop development platform combining real-time GMP drug product manufacturing, formulation modification, and healthy volunteer clinical evaluation in a rapid iterative cycle.","url":"/technology/translational-pharmaceutics/","verified":"2026-11-22"}